SCOR (SCR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 May, 2026Executive summary
Net income reached EUR 225 million in Q1 2026, up 12.8% year-over-year, with adjusted net income at EUR 220 million and all business segments contributing positively.
Annualized ROE was 21.7%, up 3.0 percentage points year-over-year, exceeding Forward 2026 targets.
Economic Value grew 7.4% versus FY2025, reaching EUR 9.0 billion.
Solvency ratio improved to 220%, a 5-point increase from FY2025, supported by strong operating capital generation.
EUR 300 million buffer added to P&C best estimate liabilities, reflecting prudent reserving for Middle East conflict.
Financial highlights
Insurance revenue was EUR 3.8 billion, down 6.1% year-over-year, mainly due to FX effects.
Combined ratio at 80.2%, improved from 85.0% in Q1 2025, with nat cat ratio of 4.2% due to benign quarter.
Insurance service result increased 11.9% to EUR 362 million; operating result rose 11.4% to EUR 353 million.
Return on invested assets was 3.8%, with regular income yield at 3.6%.
Operating cash flow was EUR 149 million, with total liquidity at EUR 2.4 billion.
Outlook and guidance
Confident in delivering the Forward 2026 plan, with capital and cash generation to remain a focus.
Full-year Solvency II capital generation guidance of 3-5 points reaffirmed, with Q1 already at the top of the range due to low nat cat activity.
Ongoing competitive market conditions anticipated for the remainder of 2026 renewals, with continued underwriting discipline and margin protection.
Forward 2026 assumptions include a solvency ratio in the 185%-220% range and annualized RoE above 12%.
Latest events from SCOR
- FY net income up to EUR 851M, ROE above 19%, dividend EUR 1.9/share, solvency 215%.SCR
Q4 20254 Mar 2026 - Q2 2024 net loss driven by L&H review, but P&C and solvency remain strong.SCR
Q2 202410 Feb 2026 - H1 2025 net income EUR 425m, ROE 20.3%, P&C combined ratio 82.5%, solvency 210%.SCR
Q2 202510 Feb 2026 - January 2026 renewals drove 14.8% EGPI growth and improved underwriting in a competitive market.SCR
Investor update4 Feb 2026 - Strong P&C and investment results offset by L&H review, solvency robust at 203%.SCR
Q3 202414 Jan 2026 - Forward 2026 targets 9% value growth, >12% ROE, higher-margin L&H, and robust solvency.SCR
Investor Day 202411 Jan 2026 - 9.6% EGPI growth driven by Specialty and Alternative Solutions, with stable profitability.SCR
Investor Update9 Jan 2026 - Q4 2024 net income EUR 233m, adjusted FY net income EUR 728m, solvency at 210%, dividend EUR 1.8.SCR
Q4 202413 Dec 2025 - Q1 2025 net income hit EUR 200m, with robust solvency and strong segment performance.SCR
Q1 202518 Nov 2025